CAMBRIDGE, Mass., Jun 26, 2002 (BUSINESS WIRE) -- Alkermes, Inc. (Nasdaq: ALKS) will host a conference call at 4:30pm EDT on Thursday, June 27, 2002, to discuss the Company's financial results for the year ending March 31, 2002. Management will review the year and provide an update on the company.
The conference call may be accessed by dialing 1-888-689-9339 for domestic callers and 1-334-323-2940 for international callers. The passcode is 6512#. Additionally, the call will be webcast on the investor relations section of Alkermes' website at www.alkermes.com.
A replay of the conference call will be available from 7:00pm EDT on June 27, 2002 through 5:00pm EDT on July 1, 2002, and may be accessed by visiting Alkermes' website or by dialing 1-888-258-7854 for domestic callers and 1-703-925-2490 for international callers. The passcode is 33680.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. The Company has several areas of focus including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks using its ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on its proprietary AIR(TM) pulmonary technology. In addition to the Company's Cambridge, Massachusetts headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT: Alkermes, Inc., Director, Investor Relations, Rebecca Peterson, (617) 583-6378